TABLE 1

Effect of amino acid at position 87 in CYP102A1 M11H on the GSH conjugation to reactive metabolites formed by oxidative bioactivation of clozapine

Concentration of metabolites (μM) formed after 30-min incubations of 200 nM CYP102A1 with 500 μM clozapine and 8 μM GST P1-1 in the presence of 100 μM GSH. Values represent averages of three individual experiments; S.E.s were always less than 10%.

C-1C-2C-3C-4C-5CG-1CG-2CG-3CG-4CG-5CG-6CG-7CG-8Specific ActivityaPercentage Conversion
m/z (MH+)343313301287329632618632632632598903584
Apolar side chain
    Gly870.40.70.1N.D.N.D.1.1N.D.0.1N.D.1.22.70.50.41.21.4
    Ala8735.182.51.12.07.813.70.71.00.314.426.14.02.531.938.2
    Val8715.190.10.91.07.19.30.70.80.311.715.85.52.926.932.3
    Leu871.09.00.30.1N.D.3.20.10.50.34.76.31.20.64.65.5
    Ile876.871.40.50.30.69.60.50.80.4N.D.20.72.91.621.625.9
    Phe878.710.50.20.2N.D.18.20.20.90.316.737.25.32.216.820.1
    Trp8711.646.9N.D.N.D.N.D.5.0N.D.N.D.N.D.5.47.62.70.813.316.0
    Met870.75.50.10.1N.D.2.8N.D.0.3N.D.3.55.1N.D.0.73.23.8
    Pro871.44.6N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.Q.b1.2
Polar uncharged side chain
    Tyr8716.573.40.90.95.26.70.30.50.28.111.53.01.121.425.7
    Gln873.26.40.10.1N.D.8.50.10.70.39.713.91.92.17.99.4
    Asn870.73.20.20.2N.D.2.3N.D.0.2N.D.2.84.71.00.72.63.2
    Cys870.21.00.3N.D.N.D.1.0N.D.N.D.N.D.1.02.0N.D.N.D.0.91.1
    Ser87N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.
    Thr87N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.
Polar charged side chain
    Asp878.513.6N.D.N.D.N.D.3.7N.D.N.D.N.D.3.77.10.30.3N.Q.b7.4
    Glu870.64.30.10.1N.D.1.7N.D.N.D.N.D.1.73.10.5N.D.2.02.4
    His870.91.30.30.1N.D.0.9N.D.N.D.N.D.1.11.6N.D.N.D.1.01.2
    Arg871.74.5N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.N.D.1.01.2
  • N.D., not detected.

  • a Presented as nmol product/nmol CYP102A1/30 min.

  • b N.Q., not quantified because P450 concentration could not be quantified (CO difference spectrum only showed a peak at 420 nm).